Viewing Study NCT06676293


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2025-12-25 @ 11:21 PM
Study NCT ID: NCT06676293
Status: COMPLETED
Last Update Posted: 2024-11-07
First Post: 2024-11-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal Carcinoma
Sponsor: Chang Gung Memorial Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module